Lecanemab four-year efficacy and safety data to be presented at AAIC 2025
Go back to Lecanemab four-year efficacy and safety data to be presented at AAIC 2025| BARNES GROUP, Inc. (NYSE: B) | Delayed: 41.09 -1.79 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.88 | 52 Week High | $44.27 | |||
| Open | $40.89 | 52 Week Low | $30.07 | |||
| Day High | $41.72 | P/E | 31.37 | |||
| Day Low | $40.60 | EPS | $1.31 | |||
| Volume | 9,859,051 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 7.18 +0.13 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.05 | 52 Week High | $8.73 | |||
| Open | $7.11 | 52 Week Low | $2.86 | |||
| Day High | $7.43 | P/E | N/A | |||
| Day Low | $6.96 | EPS | $-3.82 | |||
| Volume | 800,140 | |||||
